STAT+: Pharmalittle: We’re reading about a change in obesity drug warnings, FDA approvals, and more
Good morning, everyone, the middle of the week has arrived and this calls for a celebratory cup or two of stimulation. How so? Well, you made it this far, which can be an accomplishment, after all. Moreover, there is always good reason to forge ahead, given that there is so much more to do and […]
Here’s what’s on South Africa’s 2026 public health agenda
South Africa is a study in contrasts. And the 2026 public health agenda is no exception. Breakthrough HIV prevention medicine has arrived alongside US funding cuts. AI could revolutionise TB screening but drug resistance is climbing. New obesity drugs have launched but are unaffordable to nearly everyone. National Health Insurance (NHI) is law but is […]
JPM26: Novo Nordisk CEO reflects on ‘curse of a leader’ as company looks to reassert GLP-1 footing
The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out for 2026, new CEO Maziar Mike Doustdar appears confident in his commercial and R&D battle plan for the coming months.
Tucker Carlson Faces Ozempic Rumours After Gaunt Appearance In New Photos Sparks Concern
Tucker Carlson’s gaunt appearance sparks Ozempic rumours as weight-loss drugs become mainstream. Explore the latest speculation and why celebrities are turning to GLP-1 medications.
FDA moves to strike suicide risk warnings from 3 GLP-1s
The FDA is requesting that drugmakers remove suicidal ideation and behavior warnings from the labeling of three GLP-1 receptor agonists — Saxenda (liraglutide), Wegovy (semaglutide) and Zepbound (tirzepatide) — effective Jan. 13, 2026. The FDA’s decision follows a meta-analysis of 91 placebo-controlled trials comprising 107,910 patients, according to a Jan. 13 FDA news release. Of […]
Correction: Improvement effect of a next-generation probiotic L. plantarum-pMG36e-GLP-1 on type 2 diabetes mellitus via the gut–pancreas–liver axis
Food Funct., 2026, Advance ArticleDOI: 10.1039/D6FO90005D, Correction Open Access This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Hong Hu, Jie Luo, Ying Liu, Hongyu Li, Rui Jin, Shengjie Li, Jing Wei, Hong Wei, Tingtao ChenTo cite this article before page numbers are assigned, use the DOI form of citation above.The […]
Nimbus Healthcare and Snap Kitchen Launch “Nimbus Meals” to Pair GLP-1 Therapy with Medically Tailored Meals
Texas-founded partnership debuts a 12-week GLP-1 + food-as-medicine program built for sustainable metabolic health and employer-ready deployment AUSTIN, Texas, Jan. 14, 2026 /PRNewswire/ — Nimbus Healthcare announced Nimbus Meals by Snap Kitchen, a 12-week program that integrates GLP-1…
Cardiologist with 20 years of experience shares the truth behind GLP-1 drugs and weight loss: ‘Disaster always follows…’
Dr Bhojraj explains that GLP-1 isn’t a medication but a natural hormone, and while it can help, they have side effects and aren’t meant for lifelong use.
4 Mistakes People Make When Starting a GLP-1 That Can Stall Weight Loss—Plus How to Maximize Your Results – Woman’s World
4 Mistakes People Make When Starting a GLP-1 That Can Stall Weight Loss—Plus How to Maximize Your Results Woman’s World Study Finds More Than a Quarter of Adults Worldwide Could Benefit from GLP-1 Medications for Weight Loss (Jan 8, 2026) Kiel Institute How do semaglutides or GLP1’s work? Yahoo News Canada Tune into Living Oklahoma for insights on […]
Popular weight-loss drugs shouldn’t carry suicide warnings, FDA says
Federal regulators have told drugmakers Novo Nordisk and Eli Lilly to remove label warnings about potential suicidal thoughts and behaviours from their blockbuster weight-loss medications. The US Food and Drug Administration on Tuesday said a comprehensive review found no increased risk related to suicide among users of the GLP-1 drugs for obesity, including Novo Nordisk’s […]